What does Spark Biomedical do?
Spark Biomedical is a health tech company specializing in wearable neurostimulation technology for bioelectronic medicine. The company develops innovative treatment options across neurological health, hemostasis, women’s health, pediatrics, and chronic pain.
How much did they raise?
The company secured $15M in Series A funding, led by WAVE Ventures with participation from Pathway to Cures.
What are their plans for the money?
The funds will be used to accelerate the development of its bioelectronic treatments, potentially enhancing treatment options and patient outcomes in areas such as neurological health, hemostasis, and women’s health.
What have they achieved so far?
Under the leadership of CEO Daniel Powell, Spark Biomedical has already made strides in bringing new wearable neurostimulation treatment options to market, empowering healthcare providers and researchers with advanced bioelectronic solutions.
